Fastest Growing Canadian Companies by Revenue — Health Care
Canadian companies ranked by year-over-year revenue growth.
Updated October 14, 2026200 companiesTotal market cap $524.0B
Showing 200 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | Revenue (TTM) | Revenue Growth (YoY) |
|---|---|---|---|---|---|
| 1 | Axe Compute Inc. | AGPU:US | $135M | $3M | 119772.90% |
| 2 | Precision BioSciences Inc | DTIL:US | $180M | $45M | 37272.40% |
| 3 | 4D Molecular Therapeutics Inc | FDMT:US | $736M | $92M | 25106.70% |
| 4 | Septerna, Inc. Common Stock | SEPN:US | $1.8B | $99M | 22375.60% |
| 5 | Vir Biotechnology Inc | VIR:US | $2.0B | $303M | 19582.50% |
| 6 | Nakamoto Inc. | NAKA:US | $153M | $28M | 8680.10% |
| 7 | MeiraGTx Holdings PLC | MGTX:US | $997M | $398M | 8608.60% |
| 8 | Adagene Inc | ADAG:US | $185M | $9M | 7332.80% |
| 9 | Precigen Inc | PGEN:US | $2.7B | $86M | 6322.70% |
| 10 | Helius Medical Technologies Inc Class A | HSDT:US | $156M | $12M | 5774.40% |
| 11 | Connect Biopharma Holdings Ltd | CNTB:US | $55M | $3M | 5666.70% |
| 12 | Aethlon Medical Inc | AEMD:US | $9M | $574,245 | 4278.20% |
| 13 | Therma Bright Inc | THRM:V | $2M | $135,824 | 3771.40% |
| 14 | Protagonist Therapeutics Inc | PTGX:US | $9.3B | $282M | 3749.20% |
| 15 | Aligos Therapeutics Inc | ALGS:US | $33M | $32M | 2778.50% |
| 16 | Abeona Therapeutics Inc | ABEO:US | $282M | $26M | 2745.00% |
| 17 | Janux Therapeutics Inc | JANX:US | $1.1B | $24M | 2177.90% |
| 18 | CG Oncology, Inc. Common stock | CGON:US | $5.7B | $6M | 1982.70% |
| 19 | HCW Biologics Inc | HCWB:US | $4M | $7M | 1969.70% |
| 20 | Liquidia Technologies Inc | LQDA:US | $2.5B | $451M | 1842.70% |
| 21 | Verastem Inc | VSTM:US | $759M | $88M | 1775.40% |
| 22 | Hyperion DeFi, Inc. | HYPD:US | $52M | $1M | 1559.50% |
| 23 | Pasithea Therapeutics Corp | KTTA:US | $16M | $486,559 | 1498.10% |
| 24 | Praxis Precision Medicines Inc | PRAX:US | $7.3B | $7M | 1349.10% |
| 25 | AC Immune Ltd | ACIU:US | $249M | $18M | 1057.20% |
| 26 | Crispr Therapeutics AG | CRSP:US | $5.2B | $13M | 1041.40% |
| 27 | Arvinas Inc | ARVN:US | $487M | $317M | 1014.70% |
| 28 | Moolec Science SA Ordinary Shares | MLEC:US | $1M | $8M | 948.30% |
| 29 | Exicure Inc | XCUR:US | $7M | - | 928.00% |
| 30 | Rani Therapeutics Holdings Inc | RANI:US | $112M | $5M | 893.00% |
| 31 | KDA Group Inc | KDA:V | $13M | $419,129 | 791.20% |
| 32 | Bio Green Med Solution, Inc. | BGMS:US | $6M | $2M | 710.00% |
| 33 | Virax Biolabs Group Limited Ordinary Shares | VRAX:US | $3M | $12,423 | 684.90% |
| 34 | Immutep Ltd ADR | IMMP:US | $27M | $20M | 633.50% |
| 35 | Tonix Pharmaceuticals Holding Corp | TNXP:US | $125M | $29M | 577.90% |
| 36 | Bullfrog AI Holdings, Inc. Common Stock | BFRG:US | $11M | $298,798 | 547.60% |
| 37 | VistaGen Therapeutics Inc | VTGN:US | $10M | $3M | 504.90% |
| 38 | Dare Bioscience Inc | DARE:US | $15M | $1M | 499.60% |
| 39 | Nyxoah | NYXH:US | $139M | $22M | 472.80% |
| 40 | Kymera Therapeutics Inc | KYMR:US | $9.3B | $105M | 466.40% |
| 41 | PAVmed Inc | PAVM:US | $22M | $112,000 | 450.00% |
| 42 | Scienture Holdings, Inc. | SCNX:US | $6M | $821,315 | 449.10% |
| 43 | Hydreight Technologies Inc | NURS:V | $195M | $78M | 421.40% |
| 44 | Altimmune Inc | ALT:US | $508M | $31,000 | 420.00% |
| 45 | Surrozen Inc | SRZN:US | $349M | $12M | 408.60% |
| 46 | Regenxbio Inc | RGNX:US | $533M | $174M | 405.70% |
| 47 | Mesoblast Ltd | MESO:US | $1.9B | $120M | 390.70% |
| 48 | Apollomics Inc. Class A Ordinary Shares | APLM:US | $62M | $9M | 380.80% |
| 49 | MacroGenics Inc | MGNX:US | $237M | $175M | 378.00% |
| 50 | X4 Pharmaceuticals Inc | XFOR:US | $280M | $16M | 346.30% |
| 51 | Pharmacielo Ltd | PCLO:V | $11M | $4M | 331.00% |
| 52 | YD Bio Ltd | YDES:US | $477M | $1M | 314.90% |
| 53 | Kazia Therapeutics Ltd ADR | KZIA:US | $137M | $2M | 312.40% |
| 54 | MedMira Inc | MIR:V | $42M | $370,568 | 308.00% |
| 55 | Sinovac Biotech Ltd | SVA:US | $642M | $511M | 303.70% |
| 56 | Insmed Inc | INSM:US | $21.5B | $1.1B | 296.10% |
| 57 | Atea Pharmaceuticals Inc | AVIR:US | $413M | $192M | 295.20% |
| 58 | Dianthus Therapeutics Inc. | DNTH:US | $4.5B | $2M | 294.30% |
| 59 | Viridian Therapeutics Inc | VRDN:US | $2.1B | $71M | 278.70% |
| 60 | Alpha Cognition Inc | ACOG:US | $193M | $15M | 267.60% |
| 61 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | CUPR:US | $12M | $49,894 | 267.40% |
| 62 | Agios Pharm | AGIO:US | $1.9B | $98M | 259.30% |
| 63 | INmune Bio Inc | INMB:US | $49M | - | 257.10% |
| 64 | OmniAb Inc. | OABI:US | $694M | $38M | 244.20% |
| 65 | MediciNova Inc | MNOV:US | $75M | $920,481 | 240.60% |
| 66 | Clene Inc. | CLNN:US | $55M | $197,000 | 233.30% |
| 67 | Editas Medicine Inc | EDIT:US | $445M | $47M | 232.30% |
| 68 | SINTX Technologies Inc | SINT:US | $14M | $1M | 199.30% |
| 69 | UroGen Pharma Ltd | URGN:US | $1.8B | $189M | 199.20% |
| 70 | Silence Therapeutics PLC | SLN:US | $613M | $615,000 | 197.20% |
| 71 | Adlai Nortye Ltd. American Depositary Shares | ANL:US | $916M | $18M | 178.10% |
| 72 | Taysha Gene Therapies Inc | TSHA:US | $1.5B | $5M | 171.30% |
| 73 | Arrowhead Pharmaceuticals Inc | ARWR:US | $8.6B | $669M | 171.00% |
| 74 | Avricore Health Inc | AVCR:V | $7M | $193,041 | 170.40% |
| 75 | Cue Biopharma | CUE:US | $179M | $38M | 166.70% |
| 76 | Healthcare Triangle Inc | HCTI:US | $7M | $26M | 158.40% |
| 77 | CorMedix Inc | CRMD:US | $575M | $462M | 156.50% |
| 78 | ATAI Life Sciences BV | ATAI:US | $2.7B | $4M | 137.00% |
| 79 | Xilio Development Inc | XLO:US | $60M | $64M | 131.20% |
| 80 | Tenon Medical Inc | TNON:US | $9M | $5M | 126.80% |
| 81 | BridgeBio Pharma Inc | BBIO:US | $12.8B | $713M | 120.40% |
| 82 | ProQR Therapeutics BV | PRQR:US | $230M | $18M | 120.40% |
| 83 | Autolus Therapeutics Ltd | AUTL:US | $463M | $117M | 118.40% |
| 84 | Senseonics Holdings, Inc. Common Stock | SENS:US | $475M | $49M | 117.80% |
| 85 | RenovoRx Inc | RNXT:US | $58M | $2M | 115.40% |
| 86 | Ascendis Pharma AS | ASND:US | $15.1B | $1.0B | 114.70% |
| 87 | ARS Pharmaceuticals, Inc | SPRY:US | $416M | $117M | 114.20% |
| 88 | Foghorn Therapeutics Inc | FHTX:US | $119M | $37M | 112.70% |
| 89 | Aktis Oncology, Inc. Common stock | AKTS:US | $1.0B | $10M | 111.40% |
| 90 | STAAR Surgical Company | STAA:US | $1.1B | $340M | 111.00% |
| 91 | Compugen | CGEN:US | $202M | $74M | 107.00% |
| 92 | Freenome, Inc. Common stock | FRNM:US | $1.7B | $35M | 106.50% |
| 93 | ABVC Biopharma Inc | ABVC:US | $27M | $797,916 | 104.50% |
| 94 | LSL Pharma Group Inc. | LSL:V | $37M | $42M | 102.70% |
| 95 | PTC Therapeutics Inc | PTCT:US | $5.3B | $1.0B | 101.50% |
| 96 | Eton Pharmaceuticals Inc | ETON:US | $1.6B | $106M | 98.60% |
| 97 | Biosyent Inc. | RX:V | $193M | $56M | 95.20% |
| 98 | Immunitybio Inc | IBRX:US | $11.1B | $166M | 93.90% |
| 99 | Immatics NV | IMTX:US | $1.1B | $42M | 93.00% |
| 100 | Syndax Pharmaceuticals Inc | SNDX:US | $1.5B | $252M | 91.80% |
| 101 | Reliq Health Technologies Inc | RHT:V | $47M | $15M | 88.50% |
| 102 | OneMedNet Corp. | ONMD:US | $23M | $1M | 88.40% |
| 103 | Phathom Pharmaceuticals Inc | PHAT:US | $587M | $240M | 88.00% |
| 104 | Fennec Pharmaceuticals Inc | FRX:TO | $521M | $59M | 85.20% |
| 105 | Fennec Pharmaceuticals Inc | FENC:US | $376M | $59M | 85.20% |
| 106 | Alamar Biosciences, Inc. Common Stock | ALMR:US | $1.8B | $100M | 82.10% |
| 107 | SeaStar Medical Holding Corporation | ICU:US | $20M | $2M | 82.00% |
| 108 | Numinus Wellness Inc | NUMI:TO | $16M | $6M | 81.60% |
| 109 | Sera Prognostics Inc | SERA:US | $80M | $70,000 | 76.50% |
| 110 | Adagio Medical Holdings, Inc Common Stock | ADGM:US | $4M | $137,000 | 75.60% |
| 111 | Innovative Eyewear Inc. | LUCY:US | $8M | $3M | 74.50% |
| 112 | Anbio Biotechnology Class A Ordinary Shares | NNNN:US | $205M | $9M | 73.90% |
| 113 | Icecure Medical | ICCM:US | $5M | $4M | 72.80% |
| 114 | Madrigal Pharmaceuticals Inc | MDGL:US | $10.9B | $1.3B | 71.20% |
| 115 | TG Therapeutics Inc | TGTX:US | $8.5B | $800M | 70.30% |
| 116 | Qilian International Holding Group Limited | BGM:US | $144M | $48M | 69.80% |
| 117 | Aequus Pharmaceuticals Inc | AQS:V | $1M | $918,468 | 69.70% |
| 118 | Tarsus Pharmaceuticals Inc | TARS:US | $3.4B | $606M | 69.40% |
| 119 | Capstone Holding Corp. Common Stock | CAPS:US | $4M | $60M | 67.10% |
| 120 | Basel Medical Group Ltd Ordinary Shares | BMGL:US | $6M | $15M | 67.10% |
| 121 | Alnylam Pharmaceuticals Inc | ALNY:US | $31.1B | $4.8B | 66.90% |
| 122 | Iovance Biotherapeutics Inc | IOVA:US | $6.6B | $325M | 65.70% |
| 123 | BillionToOne, Inc. Class A Common Stock | BLLN:US | $4.6B | $397M | 64.40% |
| 124 | Anteris Technologies Global Corp. Common Stock | AVR:US | $659M | $2M | 63.30% |
| 125 | VentriPoint Diagnostics Ltd | VPT:V | $16M | $147,773 | 61.70% |
| 126 | Kestra Medical Technologies, Ltd. Common Stock | KMTS:US | $1.6B | $107M | 59.90% |
| 127 | Sonoma Pharmaceuticals Inc | SNOA:US | $6M | $22M | 59.60% |
| 128 | Crescita Therapeutics Inc | CTX:TO | $15M | $23M | 59.40% |
| 129 | Extendicare Inc | EXE:TO | $2.5B | $2.0B | 59.40% |
| 130 | Arcutis Biotherapeutics Inc | ARQT:US | $3.3B | $464M | 59.30% |
| 131 | argenx NV ADR | ARGX:US | $51.9B | $5.3B | 59.30% |
| 132 | Redhill Biopharma Ltd | RDHL:US | $5M | - | 58.60% |
| 133 | Cronos Group Inc | CRON:US | $1.2B | $179M | 58.40% |
| 134 | Cronos Group Inc | CRON:TO | $1.7B | $179M | 58.40% |
| 135 | Carlsmed, Inc. | CARL:US | $394M | $63M | 56.70% |
| 136 | Clover Health Investments Corp | CLOV:US | $2.5B | $2.5B | 55.60% |
| 137 | Ideaya Biosciences Inc | IDYA:US | $3.5B | $234M | 55.40% |
| 138 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $6.1B | $841M | 55.40% |
| 139 | Star Equity Holdings Prf | STRRP:US | - | $210M | 54.60% |
| 140 | Star Equity Holdings Inc | STRR:US | $38M | $210M | 54.60% |
| 141 | Zevra Therapeutics Inc. | ZVRA:US | $672M | $136M | 53.30% |
| 142 | Carespan Health Inc | CSPN:V | $1M | $-145,310 | 53.10% |
| 143 | CareDx Inc | CDNA:US | $3.3B | $458M | 52.20% |
| 144 | Pulsenmore Ltd. Ordinary Shares | PLSM:US | $12M | - | 52.00% |
| 145 | Legend Biotech Corp | LEGN:US | $3.6B | $1.3B | 51.90% |
| 146 | iTonic Holdings Ltd. | ITOC:US | $30M | $556,430 | 49.50% |
| 147 | OrganiGram Holdings Inc | OGI:US | $135M | $309M | 49.40% |
| 148 | OrganiGram Holdings Inc | OGI:TO | $197M | $309M | 49.40% |
| 149 | Coya Therapeutics, Inc. Common Stock | COYA:US | $113M | $8M | 49.00% |
| 150 | Gelteq Limited Ordinary Shares | GELS:US | $5M | $471,799 | 48.90% |
| 151 | Astrana Health Inc | ASTH:US | $1.9B | $3.8B | 48.50% |
| 152 | Travere Therapeutics Inc | TVTX:US | $4.9B | $591M | 48.20% |
| 153 | Halozyme Therapeutics Inc | HALO:US | $12.5B | $1.7B | 47.70% |
| 154 | Heartflow, Inc. Common Stock | HTFL:US | $4.3B | $212M | 47.60% |
| 155 | Rhythm Pharmaceuticals Inc | RYTM:US | $6.3B | $240M | 46.90% |
| 156 | Axsome Therapeutics Inc | AXSM:US | $8.8B | $777M | 45.50% |
| 157 | Caris Life Sciences, Inc. Common Stock | CAI:US | $8.4B | $990M | 45.40% |
| 158 | Hyperfine Inc | HYPR:US | $99M | $17M | 44.80% |
| 159 | Guardant Health Inc | GH:US | $21.8B | $1.2B | 44.30% |
| 160 | Omada Health, Inc. Common Stock | OMDA:US | $1.3B | $310M | 43.10% |
| 161 | MannKind Corp | MNKD:US | $1.1B | $394M | 42.90% |
| 162 | Precision Optics Corporation, Inc. Common stock | POCI:US | $51M | $32M | 42.00% |
| 163 | Prelude Therapeutics Inc | PRLD:US | $310M | $22M | 41.00% |
| 164 | Neurocrine Biosciences Inc | NBIX:US | $14.4B | $3.4B | 39.50% |
| 165 | Coherus BioSciences Inc | CHRS:US | $165M | $51M | 39.50% |
| 166 | SS Innovations International Inc. Common Stock | SSII:US | $510M | $52M | 39.40% |
| 167 | Assembly Biosciences Inc | ASMB:US | $479M | $75M | 38.90% |
| 168 | EDAP TMS S.A. | FOCL:US | $198M | $79M | 38.80% |
| 169 | Aquestive Therapeutics Inc | AQST:US | $604M | $54M | 38.10% |
| 170 | Mirum Pharmaceuticals Inc | MIRM:US | $5.6B | $618M | 37.90% |
| 171 | Beta Bionics, Inc. Common Stock | BBNX:US | $951M | $119M | 37.80% |
| 172 | Natera Inc | NTRA:US | $57.8B | $2.7B | 37.70% |
| 173 | Incyte Corporation | INCY:US | $22.9B | $5.8B | 37.70% |
| 174 | Nano X Imaging Ltd | NNOX:US | $42M | $16M | 36.70% |
| 175 | 20/20 Biolabs, Inc. Common Stock | AIDX:US | $5M | $2M | 36.50% |
| 176 | Kyntra Bio, Inc. | KYNB:US | $25M | $5M | 36.50% |
| 177 | Kura Oncology Inc | KURA:US | $943M | $77M | 36.50% |
| 178 | Pennant Group Inc | PNTG:US | $1.4B | $1.1B | 35.80% |
| 179 | Intelligent Bio Solutions Inc. | INBS:US | $5M | $4M | 35.80% |
| 180 | Brainsway Ltd | BWAY:US | $474M | $61M | 35.40% |
| 181 | Vivos Therapeutics Inc | VVOS:US | $5M | $21M | 34.90% |
| 182 | Humacyte Inc | HUMA:US | $113M | $2M | 34.90% |
| 183 | Quanterix Corp | QTRX:US | $149M | $153M | 34.40% |
| 184 | Agenus Inc | AGEN:US | $346M | $133M | 34.40% |
| 185 | Biodesix Inc | BDSX:US | $275M | $103M | 34.20% |
| 186 | Ligand Pharmaceuticals Incorporated | LGND:US | $6.0B | $291M | 33.70% |
| 187 | MedX Health Corp | MDX:V | $16M | $569,792 | 33.70% |
| 188 | BioCryst Pharmaceuticals Inc | BCRX:US | $2.2B | $941M | 33.60% |
| 189 | Vitalhub Corp | VHI:TO | $456M | $127M | 33.00% |
| 190 | Biofrontera Inc | BFRI:US | $14M | $46M | 32.90% |
| 191 | Ironwood Pharmaceuticals Inc | IRWD:US | $631M | $389M | 32.60% |
| 192 | CeriBell, Inc | CBLL:US | $907M | $102M | 32.50% |
| 193 | Supernus Pharmaceuticals Inc | SUPN:US | $2.5B | $830M | 32.40% |
| 194 | Quipt Home Medical Corp. | QIPT:TO | $221M | $265M | 32.00% |
| 195 | Corcept Therapeutics Incorporated | CORT:US | $13.1B | $831M | 31.70% |
| 196 | Establishment Labs Holdings Inc | ESTA:US | $1.8B | $246M | 31.70% |
| 197 | Alignment Healthcare LLC | ALHC:US | $1.6B | $4.6B | 31.60% |
| 198 | Universal Ibogaine Inc | IBO:V | $2M | $2M | 30.60% |
| 199 | Aclarion Inc | ACON:US | $7M | $83,769 | 30.50% |
| 200 | Harmony Biosciences Holdings | HRMY:US | $2.3B | $960M | 30.30% |
Advertisement
Frequently Asked Questions
Which Canadian company ranks #1 by revenue growth (yoy) in Health Care?
As of October 14, 2026, Axe Compute Inc. (AGPU:US) ranks #1 in Health Care at 119772.90%.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of October 14, 2026.
How many companies are in this revenue growth (yoy) list?
This view shows 200 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Largest by Revenue
Companies with the highest annual revenue
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Earnings Growth
Companies with strongest year-over-year earnings growth